EUVIMEDEUVIMED entdecken
Crossref

Radiotherapy as an organ‐preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy

Xin-Yun Song iD, Lin Lin, Yang Yang, Hui-Hui Hu, Hong-Xuan Li, Wen Feng, Qin Zhang, Xu-Wei Cai, Xiao-Long Fu iD, Zhi-Gang Li, Jun Liu, Wen Yu iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Xin-Yun Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Organ Sparing Treatments. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the advancement of immunotherapy, neoadjuvant immunochemotherapy has emerged as an effective approach for treating locally advanced esophageal squamous cell carcinoma (LA‐ESCC). However, whether radiotherapy can serve as a reliable organ‐preserving alternative following induction immunochemotherapy (IICT), and which patient subgroups benefit most, remains uncertain. In this retrospective study, 388 patients with LA‐ESCC were analyzed, including 299 who underwent surgery and 89 who received radiotherapy after IICT. Responses to immunochemotherapy were classified as major pathologic response (MPR) or non‐MPR based on pathologic examination for surgical patients and a previously developed MPR predictive model for radiotherapy patients. Survival outcomes were assessed using the Kaplan–Meier method, while prognostic factors were evaluated through Cox regression analyses. Propensity score matching (PSM) was used to minimize confounding factors. Surgery was associated with better progression‐free survival (PFS) compared to radiotherapy ( p = 0.002 before PSM; p = 0.017 after PSM), but no significant difference in overall survival (OS) was observed ( p = 0.144 before PSM; p = 0.241 after PSM). Among MPR patients, radiotherapy achieved PFS and OS outcomes similar to surgery (PFS: p = 0.136; OS: p = 0.255) after PSM. Failure patterns differed, with local or regional recurrence being more common in the radiotherapy group, while distant metastasis was prevalent in surgery patients. Major postoperative complications occurred in 9.36% of surgery patients, and 11.2% of radiotherapy patients had grade 3–4 adverse events. These findings indicate that radiotherapy could be a safe and effective organ‐preserving alternative for LA‐ESCC patients, especially those achieving MPR, offering more personalized and less invasive treatment options while maintaining quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsOrgan Sparing TreatmentsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedNeoadjuvant TherapyEsophagectomyImmunotherapyPrognosisAdult

Stichwörter der Autor:innen

immunochemotherapylocally advanced esophageal cancermajor pathologic responseorgan preservationradiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Thoracic Surgery, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Xin-Yun Song, Xiao-Long Fu, Wen Yu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Song, X. Y., Lin, L., Yang, Y., Hu, H. H., Li, H. X., Feng, W., Zhang, Q., Cai, X. W., Fu, X. L., Li, Z. G., Liu, J., & Yu, W. (2025). Radiotherapy as an organ‐preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy. International Journal of Cancer. https://doi.org/10.1002/ijc.35515

Vancouver

Song XY, Lin L, Yang Y, Hu HH, Li HX, Feng W, et al. Radiotherapy as an organ‐preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy. International Journal of Cancer. 2025. doi:10.1002/ijc.35515

BibTeX
@article{Song2025,
  author = {Song, Xin-Yun and Lin, Lin and Yang, Yang and Hu, Hui-Hui and Li, Hong-Xuan and Feng, Wen and Zhang, Qin and Cai, Xu-Wei and Fu, Xiao-Long and Li, Zhi-Gang and Liu, Jun and Yu, Wen},
  title = {Radiotherapy as an organ‐preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35515}
}
Kostenlos starten →